Everything below concerns synaptogenesis. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-10-23. Numbers and descriptions here follow the published literature rather than marketing material.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
| Property | Value | Notes |
|---|---|---|
| Common name | Dihexa | Shorthand used in research literature and supplier catalogs. |
| CAS Registry Number | 1401708-83-5 | Identifier assigned to the synthetic peptide. |
| Molecular formula | C27H44N4O5 | Reported formula; verify with a certificate of analysis. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Typical storage | −20 °C or below, desiccated | Common condition for peptide stability. |
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
Current or previous treatment with anti-resorptive or anti-angiogenic therapy Expose bone or bone that can be probed through intra-oral or extra-oral fistula in the maxillofacial region that has persisted for longer than 8 weeks. No history of radiation therapy or metastatic disease to the jaw. Osteonecrosis, or localized death of bone tissue, of the jaws, is a rare potential complication in cancer patients receiving treatments including radiation, chemotherapy, or in patients with tumors or infectious embolic events. In 2003, reports surfaced of the increased risk of osteonecrosis in patients receiving these therapies concomitant with intravenous bisphosphonate. Matrix metalloproteinase-2 may be a candidate gene for bisphosphonate-associated osteonecrosis of the jaws, since it is the only gene known to be associated with both bone abnormalities and atrial fibrillation, another side effect of bisphosphonates. In response to the growing base of literature on this association, the United States Food and Drug Administration issued a broad drug class warning of this complication for all bisphosphonates in 2005.
== Diagnosis == Source: Diagnosis is based on history, clinical signs, and diagnostic tests. Glucose levels alone are insufficient to diagnose EMS. Many EMS horses will effectively compensate their insulin response even with insulin resistance, maintaining a blood glucose within normal limits, although usually at the high end of normal. Other factors, such as stress, feeding, inflammation, or administration of α-2 agonist drugs such as xylazine and detomidine, can falsely raise blood glucose levels. Horses with persistent hyperglycemia may have type II diabetes. Insulin normally increases after feeding, as well as secondary to cortisol (stress) and epinephrine (pain), so measurement should be avoided if any of these conditions are present. Actively laminitic horses should therefore not undergo testing until their pain and stress have been adequately controlled. Additionally, resting insulin levels may not be increased in all animal with EMS. For these reasons, dynamic tests are recommended for the diagnosis of EMS. Measurement of fasting insulin concentration involves giving a horse a single flake of hay, low in non-structural carbohydrates, at 10 pm the night before testing. Blood being drawn the following morning, usually between 8 and 10 am. Both insulin and glucose blood levels are measured. Hyperinsulinemia suggests insulin resistance. This test is easy to perform, but is less sensitive than the oral sugar test. It is best used in cases where risks of laminitis make the oral sugar test potentially unsafe.
==== Protocells ==== Microcapsules termed protocells prepared by polymer-protein hybrids are the hotspot of the research area recently, enabling various functions such as bioreactors, cascade system and multiresponsive membranes, etc.
Sources: en.wikipedia.org
=== Toning === Toners help balance the skin's pH and are typically used after cleansing but prior to moisturizing. They can have a number of benefits, depending on their formula and should be chosen to suit an individuals skin needs, such as reducing pores (using toners that have salicylic acid) for oily and acne skin types, brightening complexion (with toners that have vitamin C), soothing inflammation (via toners with ingredients such as aloe vera) for sensitive skin types or using toners that include retinol for aging skin, which can help to improve fine lines.
Mercabarna is a food-trading estate that concentrates wholesale markets (fruit and vegetables, fish and flowers) and Barcelona's abattoir, as well as a large area of complementary activities (ZAC), boasting some 450 fresh-food preparation, commercial, distribution, importing and exporting businesses. A total of 700 businesses are located within its 90-hectare site. It supplies over ten million people and is a benchmark market worldwide. Mercabarna, as public limited company, was founded in 1967 in Barcelona. In the past, wholesale food markets were situated in central locations within the city of Barcelona and occupied buildings which are now used for important social, cultural and leisure facilities. The growth of the city and of its population led to problems of all kinds for these central markets in terms of capacity, communications, the environment and so forth. Gradually, therefore, they relocated to the Mercabarna precinct. In 2019 it sold 2,355,293 tons of food, 4.2% more than in 2018. The turnover of the companies that sell there exceeds 5 billion euros. The economic crisis resulting from the COVID-19 pandemic negatively impacted the sales of some of these businesses, especially those in the hospitality and catering sector.
Dyson also did work in a variety of topics in mathematics, such as topology, analysis, number theory and random matrices. In 1973 the number theorist Hugh Lowell Montgomery was visiting the Institute for Advanced Study and had just made his pair correlation conjecture concerning the distribution of the zeros of the Riemann zeta function. He showed his formula to the mathematician Atle Selberg, who said that it looked like something in mathematical physics and that Montgomery should show it to Dyson, which he did. Dyson recognized the formula as the pair correlation function of the Gaussian unitary ensemble, which physicists have studied extensively. This suggested that there might be an unexpected connection between the distribution of primes (2, 3, 5, 7, 11, ...) and the energy levels in the nuclei of heavy elements such as uranium. Around 1979 Dyson worked with the Institute for Energy Analysis on climate studies. This group, under Alvin Weinberg's direction, pioneered multidisciplinary climate studies, including a strong biology group. Also during the 1970s, Dyson worked on climate studies conducted by the JASON defense advisory group. Dyson retired from the Institute for Advanced Study in 1994. In 1998 he joined the board of the Solar Electric Light Fund. In 2003 he was president of the Space Studies Institute, the space research organization founded by Gerard K. O'Neill; in 2013 he was on its board of trustees. Dyson was a longtime member of the JASON group. Dyson won numerous scientific awards, but never a Nobel Prize.
Sources: en.wikipedia.org
Lee Waise Lee as Edward Lai (黎永廉), Secretary of Justice / co-conspirator of Peter Choi King Kong Lam as Gary Fu, Ex-Senior Inspector of Police Vincent Lam as Neo Chan, Ex-Senior Inspector of Police Wong Man-piu as Eric Ma, Ex-Senior Inspector of Police Brian Wong as Mark Cheng, Ex-Senior Inspector of Police Felix Lok as C.Y. Ma, Member of the Legislative Council / Chairman of Security Panel Council / co-conspirator of Peter Choi Terence Yin as To Man, Chief Superintendent, Director of Information Technology Jeannie Chan as Nicole Chan, ICAC Assistant Investigator Kathy Yuen as Cecilia Lai, Probationary Inspector of Police and secretary to Commissioner Dexter Young as Senior Inspector of Police, Technology Crime Division Queenie Chu as Amber Tsui, cigar lounge owner / co-conspirator of Peter Choi Leila Tong as Karen Tang, hostage
Their influx through slow channels means that the sinoatrial cells have a prolonged "plateau" phase when they have a positive charge. A part of this is called the absolute refractory period. Calcium ions also combine with the regulatory protein troponin C in the troponin complex to enable contraction of the cardiac muscle, and separate from the protein to allow relaxation. The adult resting heart rate ranges from 60 to 100 bpm. The resting heart rate of a newborn can be 129 beats per minute (bpm) and this gradually decreases until maturity. An athlete's heart rate can be lower than 60 bpm. During exercise the rate can be 150 bpm with maximum rates reaching from 200 to 220 bpm.
=== Class I === Class I fusion proteins resemble influenzavirus hemagglutinin in their structure. Post-fusion, the active site has a trimer of α-helical coiled-coils. The binding domain is rich in α-helices and hydrophobic fusion peptides located near the N-terminus (some examples show internal fusion peptides, however). Fusion conformation change can often be controlled by pH.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.
It is produced by chemical synthesis, not extracted from plants or animals. Its design is based on a naturally occurring peptide fragment. Suppliers sell it as a research chemical.
No, dihexa is a modified analog of angiotensin IV. The two share a structural relationship but differ in chemical details. Research on one does not automatically apply to the other.
Dihexa is a synthetic peptide analog of angiotensin IV, often described as an HGF mimetic in research literature. It is studied for effects on synaptic connectivity in laboratory models. It is not an approved medication.